Join us on April 30th for our 2025 Global Food & Beverage Project Spending Outlook! RSVP Today!
Sales & Support: +1 800 762 3361
Member Resources
Weight Loss Drugs Fuel Buyouts and Plant Expansions

GALWAY, IRELAND--February 8, 2024--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--The rocketing demand for weight loss drugs over the past couple of years has spurred a major spike in investment in manufacturing projects and takeovers, led by market-leader pharmaceutical company Novo Nordisk A/S (NYSE:NVO) (Bagsværd, Denmark). Within this article: Details growing investment and buyouts to capitalize in rocketing success of weight-loss drugs, leading European plant projects

Login or Register for Instant Access

Subscribe Now!

(All Fields Required)

IIR Logo Globe

Site-wide Scheduled Maintenance for April 12, 2025, between 9 A.M. - 9 P.M. CST. During this time, all services will be unavailable periodically throughout the scheduled maintenance window.

×
×
Contact Us

For More Info!